CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Working Capital Ratio

OXGN's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




OXGN Working Capital Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
Y / Y Current Liabilities Change 87.61 % 79.24 % -12.11 % 9.81 % 7.74 %
Y / Y Current Assets Change -82.42 % -83.36 % -60.89 % -68.17 % -96.01 %
Working Capital Ratio MRQ 0.03 0.09 1.16 1.44 0.28
Overall Ranking # 3875 # 4763 # 1 # # 3664
Seq. Current Liabilities Change 31.67 % 107.02 % -31.12 % -0.07 % 25.79 %
Seq. Current Assets Change -62.46 % -83.53 % -44.39 % 411.39 % -64.47 %



Working Capital Ratio third quarter 2019 Comment
Due to increase in Current Liabilities in the third quarter 2019, Working Capital Ratio fell to 0.03 below Mateon Therapeutics Inc average.

Within Biotechnology & Drugs industry 177 other companies have achieved higher Working Capital Ratio than Mateon Therapeutics Inc in third quarter 2019. While Working Capital Ratio total ranking has improved so far to 3875, from total ranking in previous quarter at 4763.

Explain Working Capital Ratio
Where is OXGN most successful ?
Working Capital Ratio OXGN on the trailing twelve month basis
Working Capital Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 178
Healthcare Sector # 682
Overall Market # 3875


Working Capital Ratio Statistics
High Average Low
45.33 12.44 0.03
(Mar 31 2015)  




Financial Statements
Mateon Therapeutics Inc's Current Liabilities $ 3 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Current Assets $ 0 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2019, within Biotechnology & Drugs Industry Working Capital RatioSep 30 2019 MRQ Current AssetsSep 30 2019 MRQ Current Liabilities
Sangui Biotech International Inc  0.06 $ 0.041  Millions$ 0.634  Millions
Boston Therapeutics, Inc.  0.05 $ 0.339  Millions$ 6.362  Millions
Oncbiomune Pharmaceuticals, Inc  0.03 $ 0.378  Millions$ 14.090  Millions
Mateon Therapeutics Inc  0.03 $ 0.071  Millions$ 2.690  Millions
U.s. Stem Cell, Inc.  0.02 $ 0.183  Millions$ 8.934  Millions
Gt Biopharma, Inc.  0.02 $ 0.337  Millions$ 18.768  Millions
Biorestorative Therapies, Inc.  0.02 $ 0.223  Millions$ 13.715  Millions
Respirerx Pharmaceuticals Inc.  0.01 $ 0.107  Millions$ 7.146  Millions
Skinvisible, Inc.  0.01 $ 0.035  Millions$ 2.788  Millions
Mymetics Corp  0.01 $ 0.666  Millions$ 64.517  Millions
Mount Tam Biotechnologies, Inc.  0.01 $ 0.020  Millions$ 2.877  Millions
Nascent Biotech Inc.  0.01 $ 0.005  Millions$ 0.807  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FCUV's Profile

Stock Price

FCUV's Financials

Business Description

Fundamentals

Charts & Quotes

FCUV's News

Suppliers

FCUV's Competitors

Customers & Markets

Economic Indicators

FCUV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071